Score: 0

Covariate Adjustment for the Win Odds: Application to Cardiovascular Outcomes Trials

Published: November 18, 2025 | arXiv ID: 2511.14292v1

By: Cyrill Scheidegger, Simon Wandel, Tobias Mütze

Potential Business Impact:

Improves drug tests by accounting for patient differences.

Business Areas:
A/B Testing Data and Analytics

Covariate adjustment can enhance precision and power in clinical trials, yet its application to the win odds remains unclear. The win odds is an extension of the win ratio that includes ties. In their original form, both methods rely on comparing each individual from the treatment group to each individual from the control group in pairwise manner, and count the number of wins, losses, and ties from these pairwise comparisons. A priori, it is not clear how covariate adjustment can be implemented for the win odds. To address this, we establish a connection between the win odds and the marginal probabilistic index, a measure for which covariate adjustment theory is well-developed. Using this connection, we show how covariate adjustment for the win odds is possible, leading to potentially more precise estimators and larger power as compared to the unadjusted win odds. We present the underlying theory for covariate adjustment for the win odds in an accessible way and apply the method on synthetic data based on the CANTOS trial (ClinicalTrials.gov identifier: NCT01327846) characteristics and on simulated data to study the operating characteristics of the method. We observe that there is indeed a potential gain in power when the win odds are adjusted for baseline covariates if the baseline covariates are prognostic for the outcome. This comes at the cost of a slight inflation of the type I error rate for small sample sizes.

Country of Origin
🇨🇭 Switzerland

Page Count
19 pages

Category
Statistics:
Methodology